ResMed (RMD) Revenue — Quarter Ended Sep 30, 2025
Revenue for the quarter was essentially flat compared to the immediately preceding quarter, declining slightly. Compared to the same quarter one year earlier, revenue increased.
Key takeaway
Quarter ended Sep 30, 2025 · FY2026 Q1
Revenue for the quarter was essentially flat compared to the immediately preceding quarter, declining slightly. Compared to the same quarter one year earlier, revenue increased.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.3B
Revenue reported for this quarter.
Quarter-over-quarter
-0.9%
Change from the immediately preceding quarter.
Year-over-year
+9.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $1.3B | +10.3% |
| Mar 31, 2025 | $1.3B | +7.9% |
| Jun 30, 2025 | $1.3B | +10.2% |
| Sep 30, 2025 | $1.3B | +9.1% |
Revenue performance
The reported revenue direction was a marginal decline from the prior quarter, reflecting a slight sequential softening. On a year-over-year basis, revenue showed solid growth.
Quarterly comparison
Compared to the immediately preceding quarter, revenue decreased modestly. Compared to the same quarter one year earlier, revenue increased notably.
What to watch
The sequential revenue decline, though small, may warrant monitoring for any emerging trend.